Cellero, Visminda P.

HRN: 26-93-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTRIAXONE 1G (VIAL)
04/08/2025
04/14/2025
IV
2g
OD
Non Healing Wound
Waiting Final Action 
04/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/08/2025
04/15/2025
IV
600mg
Q8
Non Healing Wound
Waiting Final Action 
04/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/14/2025
04/21/2025
IV
4.5g
Q8
Non Healing Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: